vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and APOGEE ENTERPRISES, INC. (APOG). Click either name above to swap in a different company.
APOGEE ENTERPRISES, INC. is the larger business by last-quarter revenue ($351.4M vs $284.0M, roughly 1.2× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 4.7%, a 91.6% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.4% vs 1.6%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 2.9%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Apogee Electronics is an American manufacturer of audio interfaces, analog-to-digital and digital-to-analog converters, USB & iOS microphones, and audio production software.
ACAD vs APOG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2026
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $351.4M |
| Net Profit | $273.6M | $16.6M |
| Gross Margin | 90.8% | 22.4% |
| Operating Margin | 6.1% | 7.3% |
| Net Margin | 96.3% | 4.7% |
| Revenue YoY | 9.4% | 1.6% |
| Net Profit YoY | 90.3% | 568.8% |
| EPS (diluted) | $1.61 | $0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $351.4M | ||
| Q4 25 | $284.0M | $348.6M | ||
| Q3 25 | $278.6M | $358.2M | ||
| Q2 25 | $264.6M | $346.6M | ||
| Q1 25 | $244.3M | $345.7M | ||
| Q4 24 | $259.6M | $341.3M | ||
| Q3 24 | $250.4M | $342.4M | ||
| Q2 24 | $242.0M | $331.5M |
| Q1 26 | — | $16.6M | ||
| Q4 25 | $273.6M | $16.5M | ||
| Q3 25 | $71.8M | $23.6M | ||
| Q2 25 | $26.7M | $-2.7M | ||
| Q1 25 | $19.0M | $2.5M | ||
| Q4 24 | $143.7M | $21.0M | ||
| Q3 24 | $32.8M | $30.6M | ||
| Q2 24 | $33.4M | $31.0M |
| Q1 26 | — | 22.4% | ||
| Q4 25 | 90.8% | 23.8% | ||
| Q3 25 | 92.2% | 23.1% | ||
| Q2 25 | 92.2% | 21.7% | ||
| Q1 25 | 91.7% | 21.6% | ||
| Q4 24 | 91.6% | 26.1% | ||
| Q3 24 | 92.5% | 28.4% | ||
| Q2 24 | 92.5% | 29.8% |
| Q1 26 | — | 7.3% | ||
| Q4 25 | 6.1% | 7.1% | ||
| Q3 25 | 12.8% | 7.5% | ||
| Q2 25 | 12.2% | 2.0% | ||
| Q1 25 | 7.9% | 1.8% | ||
| Q4 24 | 59.1% | 8.4% | ||
| Q3 24 | 12.6% | 12.3% | ||
| Q2 24 | 12.6% | 12.5% |
| Q1 26 | — | 4.7% | ||
| Q4 25 | 96.3% | 4.7% | ||
| Q3 25 | 25.8% | 6.6% | ||
| Q2 25 | 10.1% | -0.8% | ||
| Q1 25 | 7.8% | 0.7% | ||
| Q4 24 | 55.4% | 6.1% | ||
| Q3 24 | 13.1% | 8.9% | ||
| Q2 24 | 13.8% | 9.4% |
| Q1 26 | — | $0.78 | ||
| Q4 25 | $1.61 | $0.77 | ||
| Q3 25 | $0.42 | $1.10 | ||
| Q2 25 | $0.16 | $-0.13 | ||
| Q1 25 | $0.11 | $0.12 | ||
| Q4 24 | $0.86 | $0.96 | ||
| Q3 24 | $0.20 | $1.40 | ||
| Q2 24 | $0.20 | $1.41 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $39.5M |
| Total DebtLower is stronger | — | $232.3M |
| Stockholders' EquityBook value | $1.2B | $511.8M |
| Total Assets | $1.6B | $1.1B |
| Debt / EquityLower = less leverage | — | 0.45× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $39.5M | ||
| Q4 25 | $177.7M | $41.3M | ||
| Q3 25 | $258.0M | $39.5M | ||
| Q2 25 | $253.6M | $32.8M | ||
| Q1 25 | $217.7M | $41.4M | ||
| Q4 24 | $319.6M | $43.9M | ||
| Q3 24 | $155.1M | $51.0M | ||
| Q2 24 | $177.1M | $30.4M |
| Q1 26 | — | $232.3M | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $285.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $511.8M | ||
| Q4 25 | $1.2B | $512.3M | ||
| Q3 25 | $917.3M | $500.2M | ||
| Q2 25 | $822.4M | $481.8M | ||
| Q1 25 | $765.2M | $487.9M | ||
| Q4 24 | $732.8M | $522.1M | ||
| Q3 24 | $577.2M | $506.4M | ||
| Q2 24 | $516.7M | $480.0M |
| Q1 26 | — | $1.1B | ||
| Q4 25 | $1.6B | $1.1B | ||
| Q3 25 | $1.3B | $1.2B | ||
| Q2 25 | $1.2B | $1.2B | ||
| Q1 25 | $1.1B | $1.2B | ||
| Q4 24 | $1.2B | $1.2B | ||
| Q3 24 | $976.9M | $917.1M | ||
| Q2 24 | $914.1M | $889.0M |
| Q1 26 | — | 0.45× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $122.5M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 7.8% |
| Cash ConversionOCF / Net Profit | -0.18× | 7.37× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $122.5M | ||
| Q4 25 | $-48.7M | $29.3M | ||
| Q3 25 | $74.3M | $57.1M | ||
| Q2 25 | $64.0M | $-19.8M | ||
| Q1 25 | $20.3M | $30.0M | ||
| Q4 24 | $40.4M | $31.0M | ||
| Q3 24 | $63.2M | $58.7M | ||
| Q2 24 | $25.0M | $5.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $22.9M | ||
| Q3 25 | $73.9M | $52.4M | ||
| Q2 25 | — | $-26.9M | ||
| Q1 25 | — | $19.1M | ||
| Q4 24 | — | $22.0M | ||
| Q3 24 | $63.2M | $50.2M | ||
| Q2 24 | — | $-1.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | 6.6% | ||
| Q3 25 | 26.5% | 14.6% | ||
| Q2 25 | — | -7.8% | ||
| Q1 25 | — | 5.5% | ||
| Q4 24 | — | 6.4% | ||
| Q3 24 | 25.2% | 14.7% | ||
| Q2 24 | — | -0.5% |
| Q1 26 | — | 7.8% | ||
| Q4 25 | — | 1.9% | ||
| Q3 25 | 0.1% | 1.3% | ||
| Q2 25 | — | 2.1% | ||
| Q1 25 | — | 3.2% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | 0.0% | 2.5% | ||
| Q2 24 | — | 2.2% |
| Q1 26 | — | 7.37× | ||
| Q4 25 | -0.18× | 1.77× | ||
| Q3 25 | 1.03× | 2.41× | ||
| Q2 25 | 2.40× | — | ||
| Q1 25 | 1.07× | 12.08× | ||
| Q4 24 | 0.28× | 1.48× | ||
| Q3 24 | 1.93× | 1.92× | ||
| Q2 24 | 0.75× | 0.18× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
APOG
| Architectural Services | $127.1M | 36% |
| Architectural Metals | $110.0M | 31% |
| Architectural Glass | $67.4M | 19% |
| Performance Surfaces | $54.3M | 15% |
